For physicians interested in regenerative medicine, understanding the relationship between cellular therapies, peptide science, and emerging clinical technologies is becoming increasingly important.
These fields continue to develop through research into cellular communication, immune regulation, tissue repair, and metabolic function. As scientific knowledge expands, so does the need for comprehensive medical education that connects different disciplines and examines their clinical relevance.
From November 27 to 29, 2026, the International Society for Stem Cell Application (ISSCA) will bring its complete educational experience to Bogotá, Colombia.
The ISSCA 128 Golden All Access pass combines an international regenerative medicine conference, the MedConnect networking reception, and two advanced physician certification programs into one three-day experience.
Hosted at Hilton Bogotá Corferias and a partner clinic in Bogotá, the program offers licensed physicians an opportunity to explore regenerative medicine from multiple perspectives, engage with an international medical community, and complete two specialized certifications during a single event.
A Comprehensive Approach to Regenerative Medicine Education
Modern regenerative medicine brings together multiple areas of biological and clinical research.
Cellular therapies, extracellular vesicles, peptide signaling, immune function, and tissue repair are frequently discussed within the same scientific landscape. However, each field involves distinct mechanisms, clinical evidence, safety considerations, and regulatory requirements.
Understanding these differences is essential for physicians who want to evaluate emerging technologies responsibly.
ISSCA 128 Golden All Access provides a structured educational experience that connects the broader scientific discussions of an international conference with two specialized certification programs.
Participants will explore the biological foundations of regenerative medicine, examine peptide-related clinical frameworks, and discuss practical considerations involving cellular technologies and regenerative protocols.
Rather than limiting their participation to one area, physicians can engage with both certification curricula and examine how their scientific foundations relate.
Golden All Access includes the complete ISSCA 128 experience: the international conference, MedConnect, Advanced Peptide Therapy Certification, and Advanced Regenerative Medicine Certification.
Day 1: International Regenerative Medicine Conference and MedConnect
The experience begins on Friday, November 27, at Hilton Bogotá Corferias with a full day dedicated to scientific education and international exchange.
The ISSCA 128 International Regenerative Medicine Conference brings together healthcare professionals and international faculty to explore developments in cellular medicine, peptide research, immunology, and emerging regenerative technologies.
Exploring the Scientific Landscape of Regenerative Medicine
The conference agenda includes discussions involving:
- Cellular therapies: Mesenchymal stromal cells (MSCs), Muse cells, natural killer cells, and their biological characteristics.
- Exosome science: Extracellular communication, secretomes, and research involving cell-derived products.
- Immunology and longevity: Chronic inflammation, immune aging, cellular senescence, and related biological pathways.
- Peptide medicine: Cellular signaling, metabolic regulation, tissue repair research, and therapeutic considerations.
- Specialty applications: Emerging regenerative approaches in musculoskeletal medicine, aesthetics, neurology, and other areas.
- Artificial intelligence: Potential applications in clinical assessment, diagnostic interpretation, and medical decision support.
These sessions provide a scientific foundation for the more specialized training that follows.
They also give physicians an opportunity to consider how different regenerative technologies are being investigated across medical specialties.
MedConnect: An Evening With the ISSCA Community
The first day continues at 7:00 PM with MedConnect, ISSCA’s international networking reception.
This gathering brings physicians and healthcare professionals together in a more informal environment, creating opportunities to exchange experiences, discuss research interests, and develop professional relationships.
For Golden All Access participants, MedConnect is an opportunity to connect with the broader ISSCA community before the two certification days.
The conference and networking reception are both included in the Golden All Access registration.
Day 2: Advanced Peptide Therapy Certification
On Saturday, November 28, the experience moves into specialized physician education with the Advanced Peptide Therapy Certification.
Held at Hilton Bogotá Corferias from 9:00 AM to 5:00 PM, the program focuses on peptide biology, therapeutic classifications, clinical frameworks, and the scientific considerations involved in evaluating peptide-based interventions.
Understanding Peptide Mechanisms and Clinical Applications
Peptides participate in numerous physiological processes, including hormonal signaling, immune regulation, metabolic activity, and cellular communication.
While certain peptide-based medications have established clinical applications, many compounds discussed in regenerative and longevity medicine remain investigational.
For this reason, understanding the quality of supporting evidence, potential adverse effects, contraindications, and regulatory status is central to responsible clinical education.
The certification covers nine educational blocks addressing:
- Foundations of peptide therapy and mechanisms of action.
- Immunological peptides and inflammatory pathways.
- Gastrointestinal health and intestinal signaling.
- Neuroendocrine function and hormonal regulation.
- Neuromodulatory peptides and cognitive research.
- Metabolic peptides and glucose regulation.
- Sexual and reproductive health.
- Regenerative peptides and tissue repair research.
- Clinical discussion, faculty Q&A, and final conclusions.
The curriculum also explores therapeutic classifications, patient assessment, dosing frameworks, administration considerations, and protocol development.
Throughout the program, physicians will have opportunities to examine clinical cases and discuss questions related to peptide therapy with the academic faculty.
Building a Foundation for Continued Peptide Education
The Bogotá certification provides an opportunity for in-person learning and professional discussion within ISSCA’s international educational environment.
Physicians interested in reviewing foundational material or continuing their studies after the event can also explore the ISSCA Advanced Peptide Therapy Online Certification.
The separate online program includes nine core modules, 52 lessons, and more than nine hours of educational content, with self-paced access and additional learning resources.
While the online program provides flexibility for independent study, Golden All Access offers the opportunity to participate in the in-person peptide certification alongside the broader ISSCA 128 experience.
Day 3: Advanced Regenerative Medicine Certification at a Partner Clinic
The final day takes participants into a clinical training environment.
On Sunday, November 29, the Advanced Regenerative Medicine Certification will take place at a partner clinic in Bogotá, from 10:00 AM to 5:30 PM.
This specialized program focuses on cellular therapies, exosome science, regenerative protocols, and practical clinical considerations.
From Cellular Biology to Clinical Training
The curriculum includes six advanced modules covering several major areas of regenerative medicine.
Participants will examine:
- Cellular science: MSCs, Muse cells, NK cells, exosomes, and the biological principles underlying regenerative technologies.
- Clinical applications: Regenerative medicine research involving musculoskeletal conditions, aesthetics, metabolic health, neurology, and pain management.
- Preparation and administration: Product handling, administration routes, dosing principles, and safety considerations.
- Regenerative peptides: Their biological characteristics and research involving tissue repair and metabolic regulation.
- Combination strategies: Scientific considerations involving cellular therapies, exosomes, peptides, PRP, and complementary technologies.
- Clinical case discussions: Patient selection, individualized protocol planning, documentation, and follow-up.
The program also includes practical training activities and discussions involving clinical procedures and protocols.
These components allow physicians to examine how regenerative medicine concepts are approached in a clinical setting while considering the regulatory and safety requirements that apply to different interventions.
The Value of Learning in a Clinical Environment
A dedicated clinical training day creates a different educational experience from attending lectures alone.
Participants can examine clinical workflows, discuss patient cases, and explore the practical considerations involved in evaluating regenerative technologies.
The Bogotá certification combines these activities with structured scientific education and guidance from ISSCA faculty.
This clinical component is among the defining features of Golden All Access.
The November 29 certification takes place at a partner clinic in Bogotá, with limited places advertised for the clinical training experience.
Participation is educational and does not establish the efficacy of investigational therapies or replace the licensing and regulatory authorization required for clinical practice.
Two Advanced Certifications Within One International Event
One of the principal advantages of Golden All Access is the opportunity to complete both specialized certification programs during the same trip to Bogotá.
Each certification has a different academic focus.
The Advanced Peptide Therapy Certification explores peptide signaling, physiological mechanisms, therapeutic classifications, and clinical protocol considerations.
The Advanced Regenerative Medicine Certification focuses on cellular technologies, exosomes, regenerative applications, and practical training in a clinical environment.
Together, they provide a broader educational perspective on two closely related areas of regenerative medicine.
What Is Included in Golden All Access?
A single registration provides:
- Full access to the ISSCA 128 International Regenerative Medicine Conference.
- Entry to the MedConnect networking reception.
- Advanced Peptide Therapy Certification on November 28.
- Advanced Regenerative Medicine Certification on November 29.
- Participation in the clinical training day at a partner clinic.
- Two official ISSCA certification credentials, upon successful completion of the respective requirements.
- Access to the educational materials and protocol resources included in the programs.
- Opportunities to connect with physicians and healthcare professionals through the ISSCA international community.
Golden All Access also provides a combined registration option for physicians who intend to complete both certifications, with a published package advantage over purchasing the two certification passes separately.
The registration is exclusively available to licensed physicians.
Professional Connections That Continue Beyond the Event
Medical education often creates opportunities that extend beyond the classroom.
An international event allows physicians to exchange experiences with colleagues working in different medical specialties, healthcare environments, and countries.
ISSCA 128 brings these perspectives together through scientific presentations, specialized training, and MedConnect.
In addition, participants become part of ISSCA’s broader educational network, which includes clinical resources, international events, and opportunities for continued professional learning.
The value of this network lies in maintaining access to educational conversations and professional connections as regenerative medicine continues to evolve.
For physicians attending Golden All Access, the three-day format provides multiple opportunities to engage with this community throughout the event.
Who Should Choose Golden All Access?
Golden All Access is designed for licensed physicians who want to participate in the complete ISSCA 128 academic program.
It may be particularly relevant to physicians working in or exploring:
- Regenerative and cellular medicine.
- Orthopedics and sports medicine.
- Integrative and longevity medicine.
- Endocrinology and metabolic health.
- Dermatology and regenerative aesthetics.
- Pain management and musculoskeletal care.
- Medical leadership and clinical program development.
The pass may also appeal to physicians who have been considering both ISSCA certification programs and prefer to complete them during a single international event.
Previous specialization in both regenerative medicine and peptide therapy is not required, although participants should have the medical background needed to engage with advanced clinical subjects.
The certifications are educational credentials awarded to eligible physicians who fulfill the respective program requirements. They do not independently authorize clinical procedures or replace local medical licensing requirements.
Three Days of Medical Education in Bogotá
ISSCA 128 Golden All Access brings together scientific exchange, specialized physician education, clinical training, and professional networking.
Over three days, participants will have access to two certification curricula and the international conference that connects them.
For physicians seeking a comprehensive educational experience, the program offers an opportunity to engage with multiple areas of regenerative medicine during one visit to Colombia.
With the event approaching, registration is open, and the current promotional registration period is scheduled to end on November 16, 2026.
Event details
- Program: ISSCA 128 Golden All Access
- Dates: November 27–29, 2026
- Conference venue: Hilton Bogotá Corferias
- Address: Carrera 37 #24-9, Bogotá, Colombia
- November 27: International Regenerative Medicine Conference, 9:00 AM – 7:00 PM
- November 27: MedConnect, 7:00 PM
- November 28: Advanced Peptide Therapy Certification, 9:00 AM – 5:00 PM
- November 29: Advanced Regenerative Medicine Certification, 10:00 AM – 5:30 PM, at a partner clinic in Bogotá
- Eligibility: Licensed physicians only
- Included: International conference, MedConnect, both certification programs, clinical training, and associated educational resources
The November 29 clinical training session has limited places, making early registration particularly relevant for physicians planning to attend the complete experience.
Register for ISSCA 128 Golden All Access in Bogotá
Join the international ISSCA community in Colombia for three days dedicated to scientific education, advanced clinical learning, and professional connections in regenerative medicine.
